Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $5,237 | 2 | 33.8% |
| Consulting Fee | $3,800 | 4 | 24.5% |
| Honoraria | $3,200 | 2 | 20.7% |
| Food and Beverage | $1,657 | 23 | 10.7% |
| Travel and Lodging | $1,188 | 2 | 7.7% |
| Unspecified | $352.00 | 6 | 2.3% |
| Education | $59.99 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $5,237 | 7 | $0 (2021) |
| UROGEN PHARMA, INC. | $4,522 | 6 | $0 (2024) |
| Boston Scientific Corporation | $3,508 | 12 | $0 (2024) |
| Janssen Research & Development, LLC | $1,447 | 4 | $0 (2019) |
| Medtronic, Inc. | $195.10 | 2 | $0 (2024) |
| Photocure Inc | $186.61 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $167.11 | 2 | $0 (2021) |
| INTUITIVE SURGICAL, INC. | $92.22 | 1 | $0 (2024) |
| Endocare, Inc. | $64.58 | 1 | $0 (2017) |
| Janssen Products, LP | $59.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.66 | 5 | Boston Scientific Corporation ($123.67) |
| 2023 | $421.50 | 6 | Boston Scientific Corporation ($140.83) |
| 2022 | $66.67 | 1 | Boston Scientific Corporation ($66.67) |
| 2021 | $3,297 | 5 | UROGEN PHARMA, INC. ($3,200) |
| 2020 | $4,152 | 6 | Boston Scientific Corporation ($3,000) |
| 2019 | $1,538 | 7 | Janssen Research & Development, LLC ($1,447) |
| 2018 | $268.89 | 5 | BOSTON SCIENTIFIC CORPORATION ($124.07) |
| 2017 | $5,354 | 5 | Innovative Medical Technologies, LLC ($5,237) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $101.65 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/05/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $73.67 | General |
| Category: LithoVue_URO | ||||||
| 09/05/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: LithoVue_URO | ||||||
| 07/16/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $92.22 | General |
| Category: SURGERY | ||||||
| 05/02/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $78.12 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/20/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $68.66 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/19/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $76.63 | General |
| Category: LithoVue_URO | ||||||
| 04/21/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $116.98 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/07/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: LithoVue_URO | ||||||
| 04/05/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $50.38 | General |
| Category: LithoVue_URO | ||||||
| 04/04/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $95.03 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2022 | Boston Scientific Corporation | General - Kidney Stone Disease (Device) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 10/16/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $82.28 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/18/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 01/22/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 2021 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 12/31/2020 | UROGEN PHARMA, INC. | JELMYTO (Drug) | — | Cash or cash equivalent | $352.00 | Research |
| Study: OLYMPUS FINAL MANUSCRIPT • Category: UROTHELIAL CANCER | ||||||
| 12/22/2020 | Boston Scientific Corporation | GENERAL - KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 11/03/2020 | Boston Scientific Corporation | GENERAL - KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 10/21/2020 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/20/2020 | Boston Scientific Corporation | GENERAL - KIDNEY STONE DISEASE (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 2020 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 11/05/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $1,147.60 | General |
| 11/05/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $135.88 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OLYMPUS FINAL MANUSCRIPT | UROGEN PHARMA, INC. | $352.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 512 | 581 | $275,133 | $47,377 |
| 2022 | 12 | 409 | 470 | $176,661 | $34,316 |
| 2021 | 13 | 467 | 543 | $343,334 | $57,214 |
| 2020 | 13 | 508 | 565 | $313,929 | $52,538 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 16 | 16 | $84,336 | $14,844 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 187 | 222 | $54,390 | $9,187 | 16.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 72 | 94 | $22,936 | $4,287 | 18.7% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 15 | 15 | $36,480 | $3,866 | 10.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 29 | 29 | $13,775 | $2,867 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 27 | 27 | $13,392 | $2,707 | 20.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $13,460 | $2,370 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 21 | $11,214 | $2,348 | 20.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 31 | 38 | $11,210 | $2,273 | 20.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 29 | 30 | $3,600 | $756.90 | 21.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 26 | 26 | $2,964 | $621.92 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $3,960 | $609.28 | 15.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 16 | 20 | $1,820 | $363.28 | 20.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 12 | 12 | $1,596 | $277.50 | 17.4% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 11 | 11 | $66,452 | $11,423 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 184 | 224 | $43,871 | $9,001 | 20.5% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 25 | 25 | $12,622 | $2,555 | 20.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 29 | 35 | $12,280 | $2,225 | 18.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 37 | 43 | $9,088 | $2,025 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $8,506 | $1,903 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 18 | $6,505 | $1,645 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 13 | $4,076 | $927.13 | 22.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $4,413 | $868.45 | 19.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 25 | 25 | $3,396 | $646.41 | 19.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 24 | 24 | $3,141 | $587.92 | 18.7% |
About Dr. Jay Raman, M.D
Dr. Jay Raman, M.D is a Urology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356479018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Raman, M.D has received a total of $15,493 in payments from pharmaceutical and medical device companies, with $395.66 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($5,237).
As a Medicare-enrolled provider, Raman has provided services to 1,896 Medicare beneficiaries, totaling 2,159 services with total Medicare billing of $191,446. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Hershey, PA
- Active Since 03/02/2007
- Last Updated 01/29/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356479018
Products in Payments
- JELMYTO (Drug) $4,522
- GENERAL - KIDNEY STONE DISEASE (Device) $3,000
- LithoVue (Device) $264.50
- INTERSTIM (Device) $195.10
- XTANDI (Drug) $167.11
- LITHOVUE (Device) $124.07
- CYSVIEW (Drug) $95.03
- Da Vinci Surgical System (Device) $92.22
- Cysview (Drug) $91.58
- General - Kidney Stone Disease (Device) $66.67
- Endocare Cryocare System (Medical Supply) $64.58
- ZYTIGA (Drug) $59.99
- CONTOUR VL VARIABLE LENGTH PERCUFLEX STENTS (Device) $52.53
- LUPRON DEPOT (Drug) $14.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Hershey
Dr. Bruce Frantz, D.o, D.O
Urology — Payments: $8,436
John Knoedler, Md, MD
Urology — Payments: $5,851
Dr. Alireza Aminsharifi, Md, MD
Urology — Payments: $4,319
Joe Littlejohn, Md, MD
Urology — Payments: $3,709
Dr. George Zahorian, D.o., F.a.c.o.s, D.O., F.A.C.O.S
Urology — Payments: $2,385
Dr. Joseph Clark, M.d, M.D
Urology — Payments: $1,567